Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Nucleic acid of recombination expression vector encoding soluble forms of CD83, host cells transformed/transfected therewith and pharmaceutical compositions containing same

Nucleic acid of recombination expression vector encoding soluble forms of CD83, host cells transformed/transfected therewith and pharmaceutical compositions containing same

US Patent 9102726 · Granted Aug 11, 2015

Estimated economic value: $1,593,000 ⓘ

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Mutant CD83 promoter and use thereof2017
Use of soluble forms of CD83 and nucleic acids encoding them for the treatment o2017
Use of soluble forms of CD83 and nucleic acids encoding them for the treatment o2017
Use of soluble forms of CD83 and nucleic acids encoding them for the treatment o2017
Use of soluble forms of CD83 and nucleic acids encoding them for the treatment o2014
Use of soluble forms of CD83 and nucleic acids encoding them for the treatment o2014
Use of soluble forms of CD83 and nucleic acids encoding them for the treatment o2014
Soluble CD83 proteins and use thereof for the treatment and prevention of a dise2012
Soluble CD83 proteins and use thereof for the treatment and prevention of a dise2012
Soluble CD83 proteins and use thereof for the treatment and prevention of a dise2012
Use of soluble forms of CD83 and nucleic acids encoding them for the treatment o2011
Use of soluble forms of CD83 and nucleic acids encoding them for the treatment o2011